Return to search

Keyhaven makes two senior hires on investment and investor relations teams

Anne Niederstaetter joined from JPMorgan and Alma Lawrie worked in investor relations at Samena Capital.

Keyhaven Capital hired Anne Niederstaetter as a partner on its investment team, and Alma Lawrie on the investor relations team. Niederstaetter will lead the firm’s efforts in German-speaking Europe. She joined from JPMorgan where she spent 20 years in investment banking roles. Lawrie joined after working in investment banking roles at Samena Capital, Gulf Capital and Deloitte Fund Placement Advisory Group.

Press Release

Keyhaven Capital (“Keyhaven”), the specialist secondaries private equity firm dedicated to European lower mid-market companies, is pleased to announce the addition of two new senior hires into investment and investor relations roles.

The hires bring Keyhaven’s headcount to 23, including 12 investment professionals, as the business continues to develop an experienced team matching deep local expertise with pan-European coverage. The hires add further depth to Keyhaven’s relationship-driven approach to deal sourcing and execution across Europe and bolster its fundraising ability.

Anne Niederstaetter joins Keyhaven as a Partner in its investment team, with responsibility for sourcing, executing and monitoring investments. Anne will lead the firm’s efforts in German speaking Europe, where recent investments include reBuy and Evago. She joins Keyhaven from JPMorgan where she spent 20 years in a variety of investment banking roles, most recently providing M&A advice, debt and equity financing to Family Investment Firms.

Alma Lawrie joins Keyhaven’s investor relations team, with responsibility for investor relations and fundraising activity. Alma has more than 20 years of private equity experience and has held investor relations and fundraising roles at Samena Capital, Dubai; Gulf Capital, Abu Dhabi; and Deloitte Fund Placement Advisory Group, London, among others.

Anne and Alma join Keyhaven at a time when despite the ongoing impact of Covid-19 across Europe, the firm is seeing a strong pipeline of opportunities to partner with local sponsors and management teams.

Commenting on the appointments, Sasha van de Water, Managing Partner at Keyhaven said: “European lower mid-market companies represent some of the most exciting and innovative companies in the world and they have the potential to bring great value to their employees and communities as well as higher returns to shareholders. This continues to be true despite the challenges brought on by the current health and economic crisis and we believe it has never been more important to provide capital and expertise to such businesses to ensure that they grow and thrive into the future.

“We are delighted to welcome Anne and Alma into the Keyhaven family, adding decades of fundraising and deal making experience, as well as valued contacts and relationships that sit at the heart of our approach to investment.”

Anne Niederstaetter added: “Keyhaven presents an exciting opportunity to join an experienced and diverse team working with some of Europe’s most dynamic businesses. I am looking forward to adding my own contacts and experience to the firm’s impressive network to source and execute deals that deliver for management, local communities and investors.”

Alma Lawrie added: “Keyhaven’s local approach and pan-European scale make for a powerful proposition for investors seeking a single access point to European businesses. I look forward to bringing this story to more investors as the firm continues to grow.”

ENDS

About Keyhaven Capital
Keyhaven is a specialist secondaries private equity firm dedicated to European lower mid-market businesses. With a diverse team, a network embedded in local markets and a flexible approach to deal making, Keyhaven works with niche industry leaders to accelerate growth, building robust, sustainable businesses that deliver for their investors, employees and local communities.

Since its foundation in 2003, Keyhaven has raised in excess of €2 billion, and made more than 56 investments across Europe. Recent investments include Optimapharm, the full-service Contract Research Organisation specializing in Phase III clinical trials in the fast-growing oncology segment, and Agrupapulpi, a leading Spanish producer and exporter of fruit and vegetables offering a fully integrated operation, from seedling to cultivation, harvesting, processing and delivery.